We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
326
American International
AIG
$41.3B
$37.9M 0.05%
711,435
+8,099
+1% +$404K
ALK icon
327
Alaska Air
ALK
$5.58B
$37.7M 0.05%
589,744
-10,753
-2% -$654K
IYG icon
328
iShares US Financial Services ETF
IYG
$2.2B
$37.7M 0.05%
844,110
-416,013
-33% -$18.2M
CDK
329
DELISTED
CDK Global, Inc.
CDK
$37.4M 0.05%
756,029
+44,135
+6% +$2.36M
STAY
330
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$37.3M 0.05%
2,210,972
-76,875
-3% -$1.36M
MBB icon
331
iShares MBS ETF
MBB
$39.1B
$37.2M 0.05%
345,500
-14,685
-4% -$1.56M
DLN icon
332
WisdomTree US LargeCap Dividend Fund
DLN
$6.39B
$37M 0.05%
763,758
+245,304
+47% +$11.7M
ORLY icon
333
O'Reilly Automotive
ORLY
$76.3B
$36.9M 0.05%
1,499,790
+99,555
+7% +$2.52M
SRCL
334
DELISTED
Stericycle Inc
SRCL
$36.7M 0.05%
769,238
-44,681
-5% -$2.27M
SPMD icon
335
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$36.4M 0.05%
1,067,152
+784,279
+277% +$26.4M
ALXN
336
DELISTED
Alexion Pharmaceuticals
ALXN
$36.3M 0.05%
277,306
-16,939
-6% -$2.18M
MAA icon
337
Mid-America Apartment Communities
MAA
$15.7B
$36.3M 0.05%
308,203
-479
-0.2% -$53.9K
DLR icon
338
Digital Realty Trust
DLR
$71.7B
$36.2M 0.05%
307,615
+43,649
+17% +$5.2M
IAA
339
DELISTED
IAA, Inc. Common Stock
IAA
$36.1M 0.05%
+930,809
New +$36.1M
WU icon
340
Western Union
WU
$2.21B
$36.1M 0.05%
1,814,286
+6,823
+0.4% +$133K
MKTX icon
341
MarketAxess Holdings
MKTX
$5.72B
$36M 0.05%
112,133
-22,044
-16% -$6.37M
ETR icon
342
Entergy
ETR
$50B
$35.8M 0.05%
695,528
-18,182
-3% -$886K
GE icon
343
GE Aerospace
GE
$384B
$35.7M 0.05%
682,004
-52,720
-7% -$2.6M
GD icon
344
General Dynamics
GD
$106B
$35.6M 0.05%
195,715
+2,619
+1% +$451K
NTR icon
345
Nutrien
NTR
$30.7B
$35.4M 0.05%
664,143
-53,125
-7% -$2.77M
HAL icon
346
Halliburton
HAL
$26.6B
$35.2M 0.05%
1,546,056
+129,696
+9% +$3.37M
IWP icon
347
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$35M 0.05%
490,518
+46,710
+11% +$3.25M
WSO icon
348
Watsco Inc
WSO
$13.6B
$34.9M 0.05%
213,606
+9,006
+4% +$1.41M
PAGP icon
349
Plains GP Holdings
PAGP
$4.9B
$34.9M 0.05%
1,396,894
+296,663
+27% +$7.17M
CLX icon
350
Clorox
CLX
$12.7B
$34.8M 0.05%
227,493
+10,183
+5% +$1.56M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.